Copyright: Beijing Minhai Biological Technology Co., Ltd.
Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
A company in the field of biomedicine that has gone through 15 years
A modern health-oriented science and technology enterprise, an international vaccine enterprise striving to build the Great Wall of National Health Protection, possessing domestic independent intellectual property rights quadruple vaccine and grasping the forefront of the world's vaccine technology. There are 25 vaccines under study, 5 of which have applied for national drug production registration approvals, 9 have obtained clinical approvals, 1 has applied for clinical research, and 10 are under preclinical research. The company is located in Daxing Biomedical Industrial Base, Zhongguancun Science and Technology Park, Daxing District, Beijing. The registered capital is 770 million yuan and the investment scale is nearly 1.9 billion yuan. The first phase covers an area of 100 mu and has been completed.
Engaged in research and development of vaccines in the field of biomedicine
15 years of development
The sales coverage is wide
Management advantages
Quality management covers the entire process from product development, trial production, raw and auxiliary materials procurement, product production process, inspection, storage and shipping of finished products
Registered capital of 770 million yuan, total area of 235 acres, R & D center has an area of 3900 square meters, with various purification and verification equipment
Resource advantage
Team Advantage
There are more than 50 middle-level management personnel and more than 100 full-time R & D personnel, of which many core technical personnel participate in multiple "863" national key research projects
The company is strong in technology and owns a domestic leading new vaccine research and development center.
Technical advantages
